The U.S. Food and Drug Administration on Wednesday approved selling the leading version of naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid ...

A common cold medicine has been deemed ineffective and will no longer be available for purchase. The Food and Drug Administration announced Wednesday its intention to remove oral phenylephrine, a ...

On Thursday, the FDA proposed removing oral phenylephrine from the list of approved active ingredients for over-the-counter (OTC) nasal decongestants, citing concerns over its effectiveness. After ...

Advisers for the US Food and Drug Administration voted unanimously on Wednesday in support of making the birth-control pill Opill available over-the-counter, saying the benefits outweigh the risks.

A pharmaceutical ingredient that’s been a key component in nasal decongestants for decades is having its efficacy called into question, and the FDA is now weighing whether to change the compound’s ...

The US Food and Drug Administration (FDA) has announced new action to encourage companies to develop naloxone products for over-the-counter (OTC) use — or apply to switch certain products from ...

On Thursday the Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter monograph drug products for the ...

VANCOUVER, British Columbia, Oct. 22, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC:BLEG), a dynamic holding company focused on ...

A common ingredient found in most oral over-the-counter cold medicines should be removed from the market because it doesn’t work, the Food and Drug Administration (FDA) says. This follows an extensive ...

The app, called Drugs@FDA Express, is a slimmed down version of the agency’s Drugs@FDA webpage. On the app, users will be able to search for information on FDA-approved brand and generic drugs and ...